New technological developments mean that there will soon be a number of new platforms to detect either viral RNA or antigens that may be deployable as Near Patient Tests or Point of Care Tests.
Mae datblygiadau technolegol yn golygu y bydd nifer o blatfformau newydd cyn hir i ganfod un ai RNA feirysol neu antigenau a ellid eu defnyddio fel Profion Lleol i Gleifion neu Brofion Pwynt Gofal.